Physician profile
Joseph E Miller
NPI 1053374496
$2,909.96
in general payments reported to CMS, 2019-2025
18 companies · $835 in 2025
The $835 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.75 · 2023: $1,343 · 2024: $647 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783 · Travel and Lodging: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.03 |
| Travel and Lodging | $1,042.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,236.03 | 2023-2025 | Intellis Adaptivestim, Interstim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $632.20 | 2024-2025 | Xifaxan, Trulance, Relistor |
| Aimmune Therapeutics, INC. | $190.66 | 2025 | Zenpep |
| Janssen Biotech, INC. | $159.16 | 2024-2025 | Tremfya, Stelara |
| Olympus America INC. | $93.10 | 2023 | Evis Exera III Gastrointestinal Videoscope, Evis Exera Lll Colonovideoscope |
| Boston Scientific Corporation | $88.34 | 2023 | Radial Jaw 4 |
| Lilly USA, LLC | $84.80 | 2024 | Omvoh |
| Medtronic USA, INC. | $84.75 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $74.42 | 2025 | Iqirvo |
| Ardelyx, INC. | $68.47 | 2024-2025 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $43.02 | 2024-2025 | Dupixent |
| Mauna Kea Technologies, INC. | $29.31 | 2025 | |
| Globus Medical, INC. | $27.85 | 2025 | Senza |
| Abbott Laboratories | $23.69 | 2023 | Proclaim |
| Axonics, INC. | $22.00 | 2024 | Axonics |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $19.26 | 2024 | Voquezna |
| Genzyme Corporation | $18.07 | 2024 | |
| Intercept Pharmaceuticals, INC. | $14.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.